SABS SAB Biotherapeutics, Inc.
$3.20▲ +4.23%
Healthcare
Other
After hours
$3.15▼ -1.63%
Oct 28, 4:46 PM ET
Volume 347.7K
Avg Volume (10D) 690.0K
Key Metrics & Fundamentals
Market Cap
$291.16M
P/E Ratio
12.4
Div Yield
0.00%
52W Range
2.44 - 5.15
% vs 50 MA
-2.32%
% vs 200 MA
-13.22%
RSI-14
56.2
MACD Histogram
+0.0700
Beta (1Y vs SPY)
1.05
Free Cash Flow
-$11.43M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$20.48M
COGS
–
Operating Exp
$23.38M
Operating Income
-$23.38M
EBIT
-$23.38M
Pretax Income
-$22.49M
Net Income
-$22.49M
EPS (Diluted)
-0.28
Price & Volume History
Loading chart…
Recent News
Top Premarket Gainers
MT Newswires · Oct 27, 2026 7:18 AM ET
SAB Biotherapeutics Highlights Diabetes Trial Progress, Human Antibody Platform
MarketBeat · Oct 23, 2026 1:02 AM ET
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
GlobeNewswire · Oct 14, 2026 8:30 AM ET
SAB Biotherapeutics Says SAB-142 Receives FDA Fast Track Designation in Type 1 Diabetes
MT Newswires · Oct 13, 2026 9:17 AM ET
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes
GlobeNewswire · Oct 13, 2026 8:30 AM ET
SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
GlobeNewswire · Oct 1, 2026 8:30 AM ET
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
GlobeNewswire · Sep 22, 2026 8:30 AM ET
SAB BIO to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 8:30 AM ET
SAB Biotherapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 7, 2026 8:03 AM ET
SAB Biotherapeutics Inc (SABS) (Q2 2026) Earnings Call Highlights: Advancing SAB142 with Strong ...
GuruFocus.com · Aug 6, 2026 7:14 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See SABS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.